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stage I or II.1-3,5,7 Although endobron-
chial ultrasound techniques can help
improve the TBNA diagnosis yield,4
they are not always available. In addi-
tion, as has been demonstrated, ‘‘classic
TBNA’’ is still important in the thoracic
sarcoidosis diagnosis.
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TABLE 1. Predictors of obtaining diagnostic samples after TBNA in sarcoidosis
Factors Diagnostic samples P value
Sex
Male 22/31 (71.0%) .2
Female 15/26 (57.7%)
Age*
<40 y 17/27 (62.9%) .9
40 y 19/30 (63.3%)
Pulmonary lesion (TCT)y
No 27/41 (65.9%) .4
Yes 9/16 (56.3%)
No. of lymph nodes punctured
One 21/32 (65.6%) .8
Two 16/25 (64.0%)
Lymph node station
Right paratracheal 15/27 (55.6%) .8
Subcarinal 27/33 (66.7%)
Otherz 7/12 (58.3%)
Diameter of the diseased lymph node*
<20 mm 20/34 (58.8%) .8
20 mm 29/48 (60.4%)
Indirect signsx
Yes 13/16 (81.2%) .08
No 36/66 (54.5%)
*Cutoff point based in the sample median. yTTC, Thoracic computed tomography. zNine hilar and 3 left paratracheal.
xExtrinsic compression, edema, or broadening of the carina in puncture sites.
Letters to the Editor
The JournalReply to the Editor:
Transbronchial needle aspiration
(TBNA) has been increasingly used
over the past several years for the patho-
logic confirmation of sarcoidosis in pa-
tients with hilar or mediastinal node
enlargement. Early studies, all per-
Supplemental material is
available online.of Thoracic and Cardiovascular Surgeformed with the standard ‘‘blind’’
method, demonstrated that the diagnosis
of sarcoidosis is feasible with TBNA
and that acceptable, yet variable, diag-
nostic yields are obtainable (46%–
90%).1-7 These studies, however, left
questions on the generalizability of the
findings inasmuch as they were mostly
retrospective,2,5-7 included small se-
ries,2,4,6-8 did not usually accept cyto-
logic TBNA samples as diagnostic,1-5,8
used only rigid needles,1 or lacked com-
puted tomographic guidance to map
lymph node areas to be sampled.4
More recently, a few studies designed
to overcome many of these design limi-
tations showed that a diagnostic yield of
more than75%is reproducible, at least in
expert settings.9-11 Nonetheless, remark-
able differences in study populations,
needle size used (19-gauge histology
versus 22-gauge cytology needle), path-
ologic examination (cytologic with or
without histologic material), availability
of a real-time imaging guide (standard,
‘‘blind’’ TBNA versus ultrasound-
guided TBNA), and on-site facilities
(presence vs absence of rapid on-site cy-
topathologic examination) make it im-
portant to comment on the findings of
these recent studies to place TBNA re-
sults in sarcoidosis into proper context.
One extremely important aspect of
the studies specifically designed to as-
sess the value of TBNA in sarcoidosis
is that they were all subject to selection
bias. The pre-test probability of sarcoid-
osis in the study populations was very
high, inasmuch as they invariably in-
cluded patients with highly suggestive
clinical and radiologic findings.3,4,7-11
As a consequence, the excellent diag-
nostic yields that the authors obtained
are likely to be reproducible in this spe-
cific scenario.The success rateofTBNA
for sarcoidosis in studies enrolling clini-
cally unselected patients with enlarged
mediastinal nodes at imaging studies is
somewhat lower and depends mostly
on the prevalence of the disease in the
population being studied. Satisfactory
(>60%) diagnostic rates were reported
in study populations with sarcoidosis
prevalence of at least 35%,12,13 whereasry c Volume 137, Number 6 1579
Letters to the Editorvariable, sometimes disappointing, re-
sultswere obtainedbelow this threshold,
even by using real-time endobronchial
ultrasound (EBUS)–guided TBNA.14-16
Another matter of debate in the med-
ical community is the reliability of a di-
agnosis of sarcoidosis based solely on
cytologic material obtained with
TBNA.6-11This topic is of particular im-
portance inasmuch as real-time EBUS-
guided TBNA, whose spread is predict-
able in the near future owing to its excel-
lent performance characteristics, yields
cytologic material inasmuch as only
22-gauge needles can be usedwith these
devices, for the time being. When deal-
ing with this topic, however, we must
first recognize that the pathologist can
identify a noncaseating granuloma but
cannot diagnose sarcoidosis, because
sarcoidal granulomas have no unique
pathologic features to differentiate
them from other granulomas, not even
at histologic examination. It is, there-
fore, the clinician’s task to rate the likeli-
hood of a diagnosis of sarcoidosis after
careful examination of clinical, radio-
logic, and pathologic findings. This
said, data from a growing body of liter-
ature suggest that the demonstration of
nonnecrotizing epithelioid granulomas
on cytologic material is feasible, and
more and more authors did recently
rely on the cytologic findings observed
in TBNA samples to strengthen a suspi-
cion of sarcoidosis raised on clinical and
radiologic grounds.6,7,9-16
No studies directly compared stan-
dard versus ultrasound-guided TBNA
in patients with suspected sarcoidosis
up to now. However, if we analyze
the characteristics and results of the
only 3 prospective studies with a study
population of more than 50 patients
that were specifically designed to assess
the value of either standard or EBUS-
guided TBNA in sarcoidosis,9-11 we
realize that the diagnostic yield is
very high (79%–91%) for both
methods, yet slightly higher for the ul-
trasound-guided technique. If we take
a closer look (Table E1), the study
populations are very similar in terms
of disease prevalence, average lymph1580 The Journal of Thoracic annode size, lymph node stations most
commonly punctured, and percentage
of patients in whom TBNA retrieved
adequate lymph node material. It
seems likely, therefore, that rapid on-
site cytopathologic examination,
which was available in studies assess-
ing ultrasound-guided TBNA, but not
in the one evaluating standard TBNA,
contributed to the extra diagnostic
value achievedwith ultrasound-guided
aspiration. A possible explanation to
the surprisingly high yield of a ‘‘blind’’
method, such as standard TBNA, is
that right paratracheal and subcarinal
stations are enlarged in many patients
with stage I and II sarcoidosis and
that the average lymph node size is
quite relevant, making sarcoidosis
a good diagnostic setting also for stan-
dard TBNA.6-11 It is widely known, in
fact, that unlike EBUS-guided TBNA,
which has an excellent diagnostic yield
regardless of size and location of
lymph nodes, standard TBNA per-
forms better in specific lymph node sta-
tions (right paratracheal, subcarinal)
and for increasingly large nodes.
So, where dowe standwith TBNA in
sarcoidosis? It is now clear that the vast
majority of patients with a likely diag-
nosis of sarcoidosis based on clinical
and radiologic grounds can safely re-
ceive a pathologic confirmation with ei-
ther EBUS-guided or standard TBNA.
This subset of patients can be offered
TBNA as the first-step diagnostic tech-
nique, in the absence of sites more eas-
ily accessible for biopsy (eg, skin,
conjunctiva, peripheral nodes). It re-
mains to be seen in future studies
whether real-time EBUS-guided
TBNA will be able to preclude the
need for surgical diagnostic procedures
(mediastinoscopy, video-assisted tho-
racic surgery) also in a substantial per-
centage of patients with sarcoidosis
who have discrete node enlargement
and no clear-cut clinical picture.
Rocco Trisolini, MD
Marco Patelli, MD
Thoracic Endoscopy and
Pulmonary Unitd Cardiovascular Surgery c June 2009Maggiore Hospital
Bologna, Italy
References
1. PauliG,PellettierA,BohnerC,RoeslinN,WarterA,
Roegel E. Transbronchial needle aspiration in the
diagnosis of sarcoidosis. Chest. 1984;85:482-4.
2. Wang KP, Johns CJ, Fuenning C, Terry PB. Flex-
ible transbronchial needle aspiration for the diag-
nosis of sarcoidosis. Ann Otol Rhinol Laryngol.
1989;98:298-300.
3. MoralesMCF, PatefieldAJ, Strollo PJ Jr, SchenkDA.
Flexible transbronchial needle aspiration in the diag-
nosis of sarcoidosis. Chest. 1994;106:709-11.
4. Leonard C, Tormey VJ, O’Keane CO, Burke CM.
Bronchoscopic diagnosis of sarcoidosis. Eur Re-
spir J. 1997;10:2722-4.
5. Bilaceroglu S, Perim K, Gunel O, Cagirici U,
Buyuksirin M. Combining transbronchial aspiration
with endobronchial and transbronchial biopsy in sar-
coidosis. Monaldi Arch Chest Dis. 1999;54:217-23.
6. Trisolini R, LazzariAgli L,Cancellieri A, Poletti V,
Tinelli C, Baruzzi C, et al. The value of flexible
transbronchial needle aspiration in the diagnosis
of stage I sarcoidosis. Chest. 2003;124:2126-30.
7. Trisolini R, Lazzari Agli L, Cancellieri A,
Poletti V, Candoli P, Paioli D, et al. Transbronchial
needle aspiration improves the diagnostic yield of
bronchoscopy in sarcoidosis. Sarcoidosis Vasc
Diffuse Lung Dis. 2004;21:147-51.
8. Fernandez-Villar A, BotanaMI, Leiro V, Represas C,
Gonzales A, Mosteiro M, et al. Clinical utility of
transbronchial needle aspiration of mediastinal lymph
nodes in the diagnosis of sarcoidosis in stages I and II.
Arch Bronchopneumol. 2007;43:495-500.
9. Trisolini R, Tinelli C, Cancellieri A, Paioli D,
AlifanoM, BoaronM, et al. Transbronchial needle as-
pirationinsarcoidosis:yieldandpredictorsofapositive
aspirate. JThoracCardiovasc Surg. 2008;135:837-42.
10. Wong M, Yasufuku K, Nakajima T, Herth FJ,
Sekine J, Shibuya K, et al. Endobronchial ultra-
sound: new insight for the diagnosis of sarcoidosis.
Eur Respir J. 2007;29:1182-6.
11. GarwoodS, JudsonMA,SilvestriG,HodaR,FraigM,
DoelkenP.Endobronchial ultrasound for thediagnosis
of sarcoidosis. Chest. 2007;132:1298-304.
12. Cetinkaya E, Yildiz P, Kadakal F, Tekin A,
Soysal F, Elibol S, et al. Transbronchial needle as-
piration in the diagnosis of intrathoracic lymphade-
nopathy. Respiration. 2002;69:335-8.
13. Cetinkaya E, Yildiz P, Altin S, Yilmaz V. Diagnos-
tic value of transbronchial needle aspiration by
Wang 22-gauge cytology needle in intrathoracic
lymphadenopathy. Chest. 2004;125:527-31.
14. Sharafkhaneh A, Baaklini W, Gorin AB, Green L.
Yield of transbronchial needle aspiration in diagno-
sis of mediastinal lesions.Chest. 2003;124:2131-5.
15. Herth FJ, Morgan RK, Eberhardt R, Ernst A. En-
dobronchial ultrasound-guided miniforceps biopsy
in the biopsy of subcarinal masses in patients with
low likelihood of non–small cell lung cancer. Ann
Thorac Surg. 2008;85:1874-9.
16. Yasufuku K, Chiyo M, Sekine Y, Chhajed PN,
Shibuya K, Iizasa T, et al. Real-time endobronchial
ultrasound guided transbronchial needle aspiration
of mediastinal and hilar lymph nodes. Chest. 2004;
126:122-8.
doi:10.1016/j.jtcvs.2008.12.016
Letters to the EditorTABLE E1. Comparative analysis of prospective studies with a study population of more than 50 patients designed to assess the yield of either
standard or ultrasound-guided TBNA in sarcoidosis
Wong,10 2007
(EBUS)
Garwood,11 2007
(EBUS)
Trisolini,9 2008
(TBNA)
Patients (No.) 65 50 61
Sarcoidosis prevalence (% study population) 94–98* 96–98y 86
Successful LN sampling (% patients) 95 92 94
Average size of sampled LNs (mm) 20 16z 18.5
Sampling in 4R and/or 7 LN areas (% total sampled LNs) 58 63 89
TBNA: diagnostic yield (%) 87–92* 84–85y 79
ROSE availability (y/n) Yes Yes No
TBNA, Transbronchial needle aspiration; EBUS, endobronchial ultrasound; ROSE, rapid on-site cytopathologic evaluation; LN, lymph node; 4R, right paratracheal; 7, subcarinal.
*Three patients with indefinite final diagnosis; prevalence and yield are provided as a range of values encompassing the worst (all patient with indefinite diagnosis did have sar-
coidosis) and best (all patient with indefinite diagnosis did not have sarcoidosis) case scenario. yOne patient with indefinite final diagnosis; prevalence and yield are provided as
a range of values encompassing the worst (all patient with indefinite diagnosis did have sarcoidosis) and best (all patient with indefinite diagnosis did not have sarcoidosis) case
scenario. zLymph node size available for 55% of the study population, and expressed as median.The Journal of Thoracic and Cardiovascular Surgery c Volume 137, Number 6 1580.e1
